Worth Watching Stock: Amsurg Corp (NASDAQ:AMSG)

The shares of Amsurg Corp (NASDAQ:AMSG) currently has mean rating of 1.85 while 5 analysts have recommended the shares as “BUY”, 6 recommended as “OUTPERFORM” and 1 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.

The company’s mean estimate for sales for the current quarter ending June-16 is 770.40 million by 12 analysts. The means estimate of sales for the year ending Dec-16 is 3.11 billion by 13 analysts.

The mean price target for the shares of Amsurg Corp (NASDAQ:AMSG) is at 91.77 while the highest price target suggested by the analysts is 100.00 and low price target is 83.00. The mean price target is calculated keeping in view the consensus of 13 brokerage firms.

The average estimate of EPS for the current fiscal quarter for Amsurg Corp (NASDAQ:AMSG) stands at 1.08 while the EPS for the current year is fixed at 4.34 by 12 analysts.

The next one year’s EPS estimate is set at 4.91 by 11 analysts while a year ago the analysts suggested the company’s EPS at 4.34. The analysts also projected the company’s long-term growth at 12.73% for the upcoming five years.

In its latest quarter ended on 31^st March 2016, Amsurg Corp (NASDAQ:AMSG) reported earnings of $0.82. The posted earnings topped the analyst’s consensus by $0.04 with the surprise factor of 5.10%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

On June 7, 2016 Amsurg Corp (NASDAQ:AMSG) announced that its management will participate in the Jefferies 2016 Healthcare Conference on Wednesday, June 8, 2016, in New York. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company’s web site starting at 3:00 p.m. Eastern Time / 2:00 p.m. Central Time.

The live audio webcast and replay of the presentation will be available on the Company’s website by going to www.amsurg.com and clicking on Investors. For the live audio, please go to the site at least 15 minutes prior to the presentation to download and install any necessary audio software. The webcast replay will be available for 30 days.

AmSurg’s Ambulatory Services Division acquires, develops and operates ambulatory surgery centers in partnership with physicians throughout the U.S. AmSurg’s Physician Services Division, Sheridan, provides outsourced physician services in multiple specialties to hospitals, ASCs and other healthcare facilities throughout the U.S., primarily in the areas of anesthesiology, radiology, children’s services, and emergency medicine. Through these businesses as of March 31, 2016, AmSurg owned and operated 256 ASCs and one surgical hospital in 34 states and the District of Columbia and provided physician services to more than 450 healthcare facilities in 29 states. AmSurg has partnerships with, or employs, over 5,000 physicians and other healthcare professionals in 38 states and the District of Columbia.